⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
camzyos.com · Healthcare
Somewhat visible. AI bots can read Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 3 times
Claude · Meta AI
#110,371 of 654,598 in Healthcare for AI visibility
5.6
/10
AEO Score
from camzyos.com
See Important Safety Information and Full Prescribing Information, including Boxed WARNING. CAMZYOS® (mavacamten) is a prescription heart medicine used for symptomatic obstructive hypertrophic cardiomyopathy (oHCM) treatment.
Higher is better · 0-10
Structured Data
1
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
6
Clear headings and answer-style content.
Entity Clarity
6
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
6
Experience, Expertise, Authority, Trust markers.
Technical AEO
7
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
5
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
9
Inbound links from other sites.
Domain Trust
3
Established authority for your domain.
Entity Presence
0
Not in AI knowledge graphs yet.
News Mentions
0
No press coverage found yet.
Community
0
No community discussion yet.
0
No Reddit mentions found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.6/10, Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment has a working base to build on - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment
Which AI engines already crawl you
Weekly ChatGPT & Claude citation tracking
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment.
Scored by Engagemii on July 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/camzyos
Cite this score: Engagemii (2026). "AEO Score for Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Treatment." Retrieved from https://engagemii.com/aeo/brands/camzyos
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform